Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration (Q73400494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

editorial

0 references

title

Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration (English)

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

3 January 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

3 January 2024

author name string

Karl Csaky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12750083

3 January 2024

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S0161642003000952?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

https://api.elsevier.com/content/article/PII:S0161642003000952?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

3 January 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

879-881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900095-2

7 January 2021

Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor

1

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor

3 January 2024

2

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

3 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders

3 January 2024

11

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

Vascular endothelial growth factor administration in chronic myocardial ischemia

3 January 2024

14

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(03)00095-2

3 January 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12750083%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference